The Dropout Rates and Associated Factors in Patients with Mood Disorders in Long-term Naturalistic Treatment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Although maintenance treatment for mood disorders is important, the treatment discontinuation rate is reported to be high. This study aimed to investigate the dropout rates and associated factors in mood disorders. Methods: The patients in a mood disorder clinic (n = 535) were examined. Demographic and clinical factors, scores of psychometric scales, time to dropout from initial treatment in patients with bipolar disorder (BP) (n = 288) and depressive disorder (DD) (n = 143) were evaluated based on database of the mood disorder clinic. Results: Among the studied patients with BP and DD, 50% showed dropout in 4.05 and 2.17 years, respectively. The mean survival times were 8.90 years in bipolar disorder I (BP-I), 5.19 years in bipolar II disorder, 3.22 years in bipolar disorder not otherwise specified, 4.24 years in major depressive disorder, and 4.03 years in other depressive disorders. In the multivariate Cox proportional hazards regression model in the BP group, diagnosis BP-I was found to be significantly related to the decrease in dropout rate (hazard ratio [HR] = 0.22, p = 0.001); however, increased past suicide attempt number was significantly related to the increase in dropout rate (HR = 1.13, p = 0.017). In the DD group, none of anxiety disorders as comorbidity, increased scores of openness, and extraversion personality were related to the increase in dropout rate. Conclusion: Patients with BP, especially BP-I, showed a lower dropout rate as compared to patients with other mood disorders.
Abstract
Objective: Although maintenance treatment for mood disorders is important, the treatment discontinuation rate is reported to be high. This study aimed to investigate the dropout rates and associated factors in mood disorders. Methods: The patients in a mood disorder clinic (n = 535) were examined. Demographic and clinical factors, scores of psychometric scales, time to dropout from initial treatment in patients with bipolar disorder (BP) (n = 288) and depressive disorder (DD) (n = 143) were evaluated based on database of the mood disorder clinic. Results: Among the studied patients with BP and DD, 50% showed dropout in 4.05 and 2.17 years, respectively. The mean survival times were 8.90 years in bipolar disorder I (BP-I), 5.19 years in bipolar II disorder, 3.22 years in bipolar disorder not otherwise specified, 4.24 years in major depressive disorder, and 4.03 years in other depressive disorders. In the multivariate Cox proportional hazards regression model in the BP group, diagnosis BP-I was found to be significantly related to the decrease in dropout rate (hazard ratio [HR] = 0.22, p = 0.001); however, increased past suicide attempt number was significantly related to the increase in dropout rate (HR = 1.13, p = 0.017). In the DD group, none of anxiety disorders as comorbidity, increased scores of openness, and extraversion personality were related to the increase in dropout rate. Conclusion: Patients with BP, especially BP-I, showed a lower dropout rate as compared to patients with other mood disorders.
참고문헌 (56)
- Boyce P, "Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence", Bipolar Disord, 20(Suppl 2), pp.25~36 (2018)
- Chen PH, "Prediction of the duration to next admission for an acute affective episode in patients with bipolar I disorder", Clin Psychopharmacol Neurosci, 21, pp.262~270 (2023)
- Peters AT, "The burden of repeated mood episodes in bipolar I disorder : results from the national epidemiological survey on alcohol and related conditions", J Nerv Ment Dis, 204, pp.87~94 (2016)
- Shim IH, "Predictors of a shorter time to hospitalization in patients with bipolar disorder : medication during the acute and maintenance phases and other clinical factors", Clin Psychopharmacol Neurosci, 15, pp.248~255 (2017)
- Gitlin M, "Treatment-resistant bipolar disorder", Mol Psychiatry, 11, pp.227~240 (2006)
- Lingam R, "Treatment non-adherence in affective disorders", Acta Psychiatr Scand, 105, pp.164~172 (2002)
- Schneck CD, "The prospective course of rapid-cycling bipolar disorder : findings from the STEP-BD", Am J Psychiatry, 165, pp.370~377 (2008)
- Colom F, "Identifying and improving non-adherence in bipolar disorders", Bipolar Disord, 7(Suppl 5), pp.24~31 (2005)
- Jung WY, "Times to discontinue antidepressants over 6 months in patients with major depressive disorder", Psychiatry Investig, 13, pp.440~446 (2016)
- Woo YS, "The Korean medication algorithm project for depressive disorder 2021 : comparisons with other treatment guidelines", Clin Psychopharmacol Neurosci, 20, pp.37~50 (2022)
- Lam RW, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy", J Affect Disord, 117(Suppl 1), pp.S26~S43 (2009)
- Demyttenaere K, "Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine", J Affect Disord, 65, pp.243~252 (2001)
- Lin EH, "The role of the primary care physician in patients’ adherence to antidepressant therapy", Med Care, 33, pp.67~74 (1995)
- Katon W, "Adequacy and duration of antidepressant treatment in primary care", Med Care, 30, pp.67~76 (1992)
- Fornaro M, "Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression", J Psychiatr Res, 136, pp.522~528 (2021)
- Moon E, "Dropout rate and associated factors in patients with bipolar disorders", J Affect Disord, 141, pp.47~54 (2012)
- Killaspy H, "Prospective controlled study of psychiatric out-patient non-attendance. Characteristics and outcome", Br J Psychiatry, 176, pp.160~165 (2000)
- Gaudiano BA, "Patients’ expectancies, the alliance in pharmacotherapy, and treatment outcomes in bipolar disorder", J Consult Clin Psychol, 74, pp.671~676 (2006)
- Miller R, "A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia", Schizophr Res, 113, pp.138~144 (2009)
- Arvilommi P, "Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study", J Affect Disord, 121, pp.116~126 (2010)
- Warden D, "Identifying risk for attrition during treatment for depression", Psychother Psychosom, 78, pp.372~379 (2009)
- Lindström L, "Maintenance therapy with second generation antipsychotics for bipolar disorder-A systematic review and meta-analysis", J Affect Disord, 213, pp.138~150 (2017)
- Simon G, "Cost-effectiveness comparisons using"real world"randomized trials : the case of new antidepressant drugs", J Clin Epidemiol, 48, pp.363~373 (1995)
- Hirschfeld RM, "The mood disorder questionnaire : a simple, patient-rated screening instrument for bipolar disorder", Prim Care Companion J Clin Psychiatry, 4, pp.9~11 (2002)
- Hong N, "Improving the screening instrument of bipolar spectrum disorders : weighted Korean version of the mood disorder questionnaire", Clin Psychopharmacol Neurosci, 16, pp.333~338 (2018)
- Ghanbari Jolfaei A, "High frequency of bipolar disorder comorbidity in medical inpatients", Iran J Psychiatry, 14, pp.60~66 (2019)
- Sanchez-Roige S, "Genome-wide association study metaanalysis of the alcohol use disorders identification test(AUDIT)in two population-based cohorts", Am J Psychiatry, 176, pp.107~118 (2019)
- Pérez-Ríos M, "Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey", BMC Public Health, 9, pp.493~ (2009)
- Kiatrungrit K, "Validity and reliability of adult ADHD self-report scale Thai version(ASRS-V1. 1 TH)", Shanghai Arch Psychiatry, 29, pp.218~227 (2017)
- Laksmita OD, "Multidimensional scale of perceived social support in Indonesian adolescent disaster survivors : a psychometric evaluation", PLoS One, 15, pp.e0229958~ (2020)
- Mikołajczyk E, "Personality dimensions measured using the temperament and character inventory(TCI)and NEO-FFI on a Polish sample", Int J Methods Psychiatr Res, 17, pp.210~219 (2008)
- Roepke S, "Personality profiles among normal aged individuals as measured by the NEO-PI-R", Aging Ment Health, 5, pp.159~164 (2001)
- Güngör BB, "Evaluation of eating attitudes, anger and impulsivity in atypical and nonatypical depression and assessment of comorbidity of binge eating", Psychiatr Danub, 32, pp.105~114 (2020)
- Mazza M, "Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder : 1-year follow-up", J Affect Disord, 115, pp.27~35 (2009)
- Demyttenaere K, "Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment", J Clin Psychiatry, 62(Suppl 22), pp.34~37 (2001)
- García S, "Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients : a systematic review", J Clin Psychopharmacol, 36, pp.355~371 (2016)
- de Assis da Silva R, "Insight across the different mood states of bipolar disorder", Psychiatr Q, 86, pp.395~405 (2015)
- Dell’Osso B, "How to improve adherence to antidepressant treatments in patients with major depression : a psychoeducational consensus checklist", Ann Gen Psychiatry, 19, pp.61~ (2020)
- Hansen HV, "Adherence to antidepressant treatment", Expert Rev Neurother, 7, pp.57~62 (2007)
- Rush AJ, "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps : a STAR*D report", Am J Psychiatry, 163, pp.1905~1917 (2006)
- Keitner GI, "Realistic expectations and a disease management model for depressed patients with persistent symptoms", J Clin Psychiatry, 67, pp.1412~1421 (2006)
- Ruberto VL, "Pharmacological treatments for patients with treatment-resistant depression", Pharmaceuticals(Basel), 13, pp.116~ (2020)
- Jeon HJ, "Long-term safety and efficacy of esketamine nasal spray plus an oral antidepressant in patients with treatment-resistant depression-an Asian sub-group analysis from the SUSTAIN-2study", Clin Psychopharmacol Neurosci, 20, pp.70~86 (2022)
- Sørensen A, "Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression : a systematic review", Ther Adv Psychopharmacol, 12, pp.20451253211067656~ (2022)
- Jiménez E, "Association between GSK3β gene and increased impulsivity in bipolar disorder", Eur Neuropsychopharmacol, 24, pp.510~518 (2014)
- Jiménez E, "Impulsivity and functional impairment in bipolar disorder", J Affect Disord, 136, pp.491~497 (2012)
- Perugi G, "Attention deficit", hyperactivity disorder symptoms in Italian bipolar adult patients : a preliminary report, 2013, pp.149, 430~434
- Kraus C, "Prognosis and improved outcomes in major depression : a review", Transl Psychiatry, 9, pp.127~ (2019)
- He C, "Amygdala connectivity mediates the association between anxiety and depression in patients with major depressive disorder", Brain Imaging Behav, 13, pp.1146~1159 (2019)
- Hung CI, "Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder", Compr Psychiatry, 52, pp.370~377 (2011)
- Sato T, "Factor validity of the temperament and character inventory in patients with major depression", Compr Psychiatry, 42, pp.337~341 (2001)
- Hansenne M, "Temperament and character inventory(TCI)and depression", J Psychiatr Res, 33, pp.31~36 (1999)
- Matsudaira T, "Personality traits as risk factors of depression and anxiety among Japanese students", J Clin Psychol, 62, pp.97~109 (2006)
- Smith DJ, "High harm avoidance and low self-directedness in euthymic young adults with recurrent, early-onset depression", J Affect Disord, 87, pp.83~89 (2005)
- Zaninotto L, "Temperament and character profiles in bipolar I, bipolar II and major depressive disorder : impact over illness course, comorbidity pattern and psychopathological features of depression", J Affect Disord, 184, pp.51~59 (2015)
- Nikolic S, "Individual and gender differences in personality influence the diagnosis of major depressive disorder", Psychiatr Danub, 32, pp.97~104 (2020)
